The number of people with susceptibility test result for rifampicin in Malta
Malta: The number of people with susceptibility test result for rifampicin was 93.1 in 2021. ▬ Flat
Latest (2021)
93.1
Change on year
up 6.8%
World rank
59th
of 146 countries
All-time high
100
in 2018
All-time low
82.22
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Malta, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Malta recorded 93.1 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 6.8% on the previous year and up 1.2% over five years.
That places Malta 59th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Malta, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 92 | — |
| 2018 | 100 | +8.7% |
| 2019 | 82.22 | -17.8% |
| 2020 | 87.18 | +6.0% |
| 2021 | 93.1 | +6.8% |
Malta compared with similar countries
- Malta's 93.1 is above the median for high income countries, which is 92.6, 1.0× the median. (56 countries reporting)
- Malta's 93.1 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 89, 1.0× the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 91.41 | 82.22 | 100 | 3 |
| 2020s | 90.14 | 87.18 | 93.1 | 2 |
Countries ranked near Malta
- 56 Kyrgyzstan 94.01 compare
- 57 Russian Federation 93.52 compare
- 58 Puerto Rico 93.33 compare
- 60 Paraguay 92.7 compare
- 61 Togo 92.42 compare
- 62 Guam 92.11 compare
More health data for Malta
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,737 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.1693 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0194 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.1495 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Malta?
- The number of people with susceptibility test result for rifampicin in Malta was 93.1 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Malta?
- The highest recorded value was 100 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Malta?
- The lowest recorded value was 82.22 in 2019.
- How does Malta rank for the number of people with susceptibility test result for rifampicin?
- Malta ranks 59th out of 146 countries with data for 2021.
- Where does this Malta data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).